Clinical trial · Interventional
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection Of Bladder Tumors: A Randomized Controlled Trial
NCT06119724CI-TRIAL-00083150TURBT-Enblocactive not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective controlled study randomized comparing bipolar enbloc versus thulium enbloc for bladder tumours
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bipolar enbloc resection of bladder tumor | Procedure | — | UNRESOLVED |
| Thulium laser enbloc resection of bladder tumor | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Bipolar enbloc resection of bladder tumors
- description
- Patients who have odd number will be in the first group which will be enrolled in bipolar enbloc group
- interventionNames
- Procedure: Bipolar enbloc resection of bladder tumor
- type
- ACTIVE_COMPARATOR
- label
- Thulium enbloc resection of bladder tumors
- description
- patients who have even number will be in the second group which will be Thulium-Yag laser enbloc group
- interventionNames
- Procedure: Thulium laser enbloc resection of bladder tumor
Primary outcomes (5)
- measure
- Enbloc technique effectiveness in obtaining muscle in the speciment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 80 Years
Show eligibility criteria text
* Inclusion criteria: 1. Patients with NMIBC 2. Bladder tumors\<4 cm in CT. 3. Resectable bladder tumors. 4. Age \<80 years. * Exclusion criteria : 1. Bladder tumours \> 4cm . 2. Metastatic bladder tumors. 3. Patients with carcinoma in situ CIS . 4. Patients with coagulopathies. 5. Domal bladder tumors.
References
Publications (0)
Data not yet available
No reference posted for this study.